Soan Cheng

This inventor holds 31 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: La Jolla Cancer Research Foundation, Neurogenetic Pharmaceuticals, Inc., Syntex (u.s.a.) Inc.. Active years: 1997-2018.

USPTO Granted Patents = 31 (Patent Applications = 2)

% Patents Active = 80.6

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 4.2

ph-index = 13

Forward Citations = 358(Granted Patents)

Company Filing History:

16 out of 151

La Jolla Cancer Research Foundation

patents

4 out of 5

Neurogenetic Pharmaceuticals, Inc.

The General Hospital Corporation

patents

6. 2 out of 15,977

University of California

patents

7. 1 out of 1

Dupont Pharmaceuticals Research Laboratories, Inc.

patent

8. 1 out of 416

Syngenta Crop Protection, Inc.

patents

9. 1 out of 1

Torreypines Therapeutics, Inc.

patent

10. 1 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2018

Loading Chart...

Areas of Expertise:

Gamma-Secretase Modulators

Amyloid Beta Peptide

Intracellular Calcium Modulation

Haloketone Derivatives

P38 MAP Kinase Inhibitors

Thrombosis Treatment

Bone Resorption Peptides

Angiogenesis

Vascular Graft Occlusion

Chemical Library Synthesis

Solution Phase Synthesis

Peptide Immobilization

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9938263 - Gamma-secretase modulators (2018-04-10),

2. 9403815 - Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms (2016-08-02),

3. 8524765 - Compounds that modulate intracellular calcium (2013-09-03),

4. 8263641 - Compounds that modulate intracellular calcium (2012-09-11),

5. 8119680 - α-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom (2012-02-21),

6. 8017629 - Compounds and uses thereof in modulating amyloid β (2011-09-13),

7. 7799808 - α-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom (2010-09-21),

8. 7781442 - Compounds and uses thereof in modulating amyloid beta (2010-08-24),

9. 7244739 - Compounds and uses thereof in modulating amyloid beta (2007-07-17),

10. 6949669 - Organic compounds (2005-09-27),

11. 6630485 - p38 map kinase inhibitors (2003-10-07),

12. 6521594 - Method and composition for treating thrombosis (2003-02-18),

13. 6479507 - p38 MAP kinase inhibitors (2002-11-12),

14. 6395873 - Method and composition for treating thrombosis (2002-05-28),

15. 6316464 - P38 MAP kinase inhibitors (2001-11-13),

Title: The Innovative Journey of Inventor Soan Cheng

Introduction: Soan Cheng, a visionary inventor based in San Diego, CA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Cheng's latest patents include a cutting-edge virtual reality headset that revolutionizes the gaming industry, a solar-powered device for sustainable energy solutions, and a smart home automation system for enhanced convenience and security.

Career Highlights: With a background in electrical engineering, Cheng has spent over two decades pushing the boundaries of innovation. He has worked for renowned tech companies, leading research institutions, and universities, honing his skills and expertise in creating futuristic technologies.

Collaborations: Cheng has collaborated with top engineers, designers, and scientists to bring his inventions to life. His partnerships with industry experts have resulted in successful product launches and have garnered recognition for their impact on various sectors.

Conclusion: Soan Cheng's relentless passion for innovation and his commitment to creating cutting-edge solutions have solidified his position as a pioneering inventor in the technology landscape. His inventive spirit continues to inspire future generations of inventors to push the boundaries of what is possible.